Azadeh Carr
Program Director of the Breast Fellowship
Contact
Persistent/Recurrent Primary Hyperparathyroidism: Does the Number of Abnormal Glands Play a Role? J Surg Res. 2020 02; 246:335-341.. View in PubMed
Confirmation of Parathyroid Tissue: Are Surgeons Aware of New and Novel Techniques? J Surg Res. 2020 02; 246:139-144.. View in PubMed
Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls Thyroid. 2018 11; 28(11):1462-1467. . View in PubMed
A postoperative parathyroid hormone-based algorithm to reduce symptomatic hypocalcemia following completion/total thyroidectomy: A retrospective analysis of 591 patients Surgery. 2018 10; 164(4):746-753. . View in PubMed
Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making J Surg Res. 2017 03; 209:162-167. . View in PubMed
Parathyroidectomy for primary hyperparathyroidism improves sleep quality: A prospective study Surgery. 2017 01; 161(1):25-34. . View in PubMed
Disparities in access to care and outcomes in patients with adrenocortical carcinoma J Surg Res. 2017 06 01; 213:138-146. . View in PubMed
Concurrent endocrine and other surgical procedures: an institutional experience J Surg Res. 2017 05 01; 211:107-113. . View in PubMed
Association between body mass index and multigland primary hyperparathyroidism J Surg Res. 2016 May 01; 202(1):132-8. . View in PubMed
Management of suspected adrenal metastases at 2 academic medical centers Am J Surg. 2016 Apr; 211(4):664-70. . View in PubMed
Intraoperative ex vivo parathyroid aspiration: A point-of-care test to confirm parathyroid tissue Surgery. 2016 10; 160(4):850-857. . View in PubMed
Response to comments on: Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy following adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol Surgery. 2016 07; 160(1):249-250. . View in PubMed
Delayed Calcium Normalization After Presumed Curative Parathyroidectomy is Not Associated with the Development of Persistent or Recurrent Primary Hyperparathyroidism Ann Surg Oncol. 2016 07; 23(7):2310-4. . View in PubMed
Minimally Invasive Adrenalectomy Surg Oncol Clin N Am. 2016 Jan; 25(1):139-52. . View in PubMed
Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol Surgery. 2016 Jan; 159(1):259-65. . View in PubMed
Institutional experience with lateral neck dissections for thyroid cancer Surgery. 2015 Oct; 158(4):972-8; discussion 978-80. . View in PubMed
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner J Biol Chem. 2015 Jun 19; 290(25):15392. . View in PubMed
A single parathyroid hormone level obtained 4 hours after total thyroidectomy predicts the need for postoperative calcium supplementation J Am Coll Surg. 2014 Oct; 219(4):757-64. . View in PubMed
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner J Biol Chem. 2014 Sep 05; 289(36):25306-16. . View in PubMed
Villin expression is frequently lost in poorly differentiated colon cancer Am J Pathol. 2012 Apr; 180(4):1509-21. . View in PubMed
After receiving her undergraduate degree from the University of Maryland, she attended medical school at Columbia University College of Physicians and Surgeons in New York. Dr. Carr completed her residency training in General Surgery at Albert Einstein-Montefiore in Bronx, NY, then went on to an Endocrine Surgery fellowship at Medical College of Wisconsin in Milwaukee, specializing in thyroid and parathyroid surgery. She stayed on as an Assistant Professor of surgery for 5 years, then came to the Keck School of Medicine of USC to complete a Breast Surgical Oncology fellowship.
Dr. Carr is focused on treating patients with benign and malignant breast, thyroid, and parathyroid disease. She is committed to patient-focused interdisciplinary care and has experience with advanced breast and endocrine surgical techniques.
